Asger Lund, Md

This study is testing if adding a low daily dose of colchicine, an existing anti-inflammatory drug, to standard diabetes care can reduce inflammation and lower the risk of heart disease in people with long-standing Type 1 diabetes. About 100 participants, who already have or are …

This study aims to understand how a natural gut hormone (GIP) and amino acids from protein work together to trigger glucagon release, which raises blood sugar. Researchers are testing this in 10 people with and without type 1 diabetes to see if these substances could help prevent…